Targeting the microbiota-immune interface with propionate to alleviate cardiovascular risk in CKD
| Institution | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) |
|---|---|
| Project leader | Nicola Wilck |
| Site | Berlin |
| Project type | Shared Expertise (SE) |
| Funding | € 29.500,00 |
| SE Trait | SE-Partner |
| SE Number | SE199 |
| Begin | 01.04.2023 |
| End | 31.03.2026 |
| Partnerprojekte |
Förderkennzeichen
81X2100172
Projektnummer
1651